Market News AIOpen the app

Myomo Q3 2026 Earnings Call Transcript

ResultsRead the original at Benzinga
Good for MYO

Myomo's sales grew, clinics sent more referrals, and expenses grew more slowly than sales, pointing to business improvement. Its $4.2 million loss tempers the report, though part came from a non-cash charge.

MYO · Myomo

AI read · Good for MYO

The AI's read

More referrals from clinics and rehabilitation centers give Myomo more ways to reach patients. Payer agreements cover 35 million additional people, and operating costs rose 6% as sales grew 22%. The company also narrowed its 2026 sales forecast to $46 million to $47 million. Its $4.2 million loss tempers the report, though the company said a non-cash charge contributed to it.

Get alerts for MYO

Follow Myomo (MYO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MYO
Free on the App Store and Google Play, or on the web.